These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 9639447

  • 21. In vitro and in vivo effects of polyhexamethylene biguanide against herpes simplex virus infection.
    Valluri S, Fleming TP, Laycock KA, Tarle IS, Goldberg MA, Garcia-Ferrer FJ, Essary LR, Pepose JS.
    Cornea; 1997 Sep; 16(5):556-9. PubMed ID: 9294689
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Effects of topical and subconjunctival cidofovir (HPMPC) in an animal model.
    Banker AS, Bergeron-Lynn G, Keefe KS, De Clercq E, Taskintuna I, Freeman WR.
    Curr Eye Res; 1998 Jun; 17(6):560-6. PubMed ID: 9663845
    [Abstract] [Full Text] [Related]

  • 24. Efficacy of (S)-HPMPA against thymidine kinase-deficient herpes simplex virus-keratitis.
    Maudgal PC, De Clercq E, Huyghe P.
    Invest Ophthalmol Vis Sci; 1987 Feb; 28(2):243-8. PubMed ID: 8591903
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A randomized, double-blind, placebo-controlled trial of cidofovir gel for the treatment of acyclovir-unresponsive mucocutaneous herpes simplex virus infection in patients with AIDS.
    Lalezari J, Schacker T, Feinberg J, Gathe J, Lee S, Cheung T, Kramer F, Kessler H, Corey L, Drew WL, Boggs J, McGuire B, Jaffe HS, Safrin S.
    J Infect Dis; 1997 Oct; 176(4):892-8. PubMed ID: 9333146
    [Abstract] [Full Text] [Related]

  • 27. Effects of topical unoprostone and latanoprost on acute and recurrent herpetic keratitis in the rabbit.
    Kaufman HE, Varnell ED, Toshida H, Kanai A, Thompson HW, Bazan NG.
    Am J Ophthalmol; 2001 May; 131(5):643-6. PubMed ID: 11336941
    [Abstract] [Full Text] [Related]

  • 28. Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study.
    Hillenkamp J, Reinhard T, Ross RS, Böhringer D, Cartsburg O, Roggendorf M, De Clercq E, Godehardt E, Sundmacher R.
    Arch Ophthalmol; 2001 Oct; 119(10):1487-91. PubMed ID: 11594949
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Topical interferon alpha-2a treatment of herpes simplex keratitis resistant to multiple antiviral medications in an immunosuppressed patient.
    Minkovitz JB, Pepose JS.
    Cornea; 1995 May; 14(3):326-30. PubMed ID: 7600820
    [Abstract] [Full Text] [Related]

  • 32. The effect of roscovitine on herpetic keratitis.
    Avunduk AM, Varnell ED, Kaufman HE.
    Exp Eye Res; 2003 Jun; 76(6):679-83. PubMed ID: 12742350
    [Abstract] [Full Text] [Related]

  • 33. The cotton rat model for adenovirus ocular infection: antiviral activity of cidofovir.
    Kaneko H, Mori S, Suzuki O, Iida T, Shigeta S, Abe M, Ohno S, Aoki K, Suzutani T.
    Antiviral Res; 2004 Jan; 61(1):63-6. PubMed ID: 14670595
    [Abstract] [Full Text] [Related]

  • 34. Efficacy of polyclonal antibodies for treatment of ocular herpes simplex infection.
    Epstein SP, Nurozler M, Smetana CR, Asbell PA.
    Cornea; 2001 Jul; 20(5):495-500. PubMed ID: 11413405
    [Abstract] [Full Text] [Related]

  • 35. Antivirals for the treatment of herpesvirus infections.
    De Clercq E.
    J Antimicrob Chemother; 1993 Jul; 32 Suppl A():121-32. PubMed ID: 8407694
    [Abstract] [Full Text] [Related]

  • 36. Ganciclovir ophthalmic gel (Virgan; 0.15%) in the treatment of herpes simplex keratitis.
    Colin J, Hoh HB, Easty DL, Herbort CP, Resnikoff S, Rigal D, Romdane K.
    Cornea; 1997 Jul; 16(4):393-9. PubMed ID: 9220235
    [Abstract] [Full Text] [Related]

  • 37. Clinical characteristics of acyclovir-resistant herpetic keratitis and experimental studies of isolates.
    Yao YF, Inoue Y, Kase T, Uchihori Y, Mori Y, Ohashi Y.
    Graefes Arch Clin Exp Ophthalmol; 1996 Aug; 234 Suppl 1():S126-32. PubMed ID: 8871163
    [Abstract] [Full Text] [Related]

  • 38. Risk factors for herpes simplex virus epithelial keratitis recurring during treatment of stromal keratitis or iridocyclitis. Herpetic Eye Disease Study Group.
    Wilhelmus KR, Dawson CR, Barron BA, Bacchetti P, Gee L, Jones DB, Kaufman HE, Sugar J, Hyndiuk RA, Laibson PR, Stulting RD, Asbell PA.
    Br J Ophthalmol; 1996 Nov; 80(11):969-72. PubMed ID: 8976723
    [Abstract] [Full Text] [Related]

  • 39. Herpetic Eye Disease Study. A controlled trial of oral acyclovir for herpes simplex stromal keratitis.
    Barron BA, Gee L, Hauck WW, Kurinij N, Dawson CR, Jones DB, Wilhelmus KR, Kaufman HE, Sugar J, Hyndiuk RA.
    Ophthalmology; 1994 Dec; 101(12):1871-82. PubMed ID: 7997323
    [Abstract] [Full Text] [Related]

  • 40. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
    Snoeck R, Andrei G, Gérard M, Silverman A, Hedderman A, Balzarini J, Sadzot-Delvaux C, Tricot G, Clumeck N, De Clercq E.
    Clin Infect Dis; 1994 Apr; 18(4):570-8. PubMed ID: 8038312
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.